Listed

CVS HEALTH Corp: Form 10-K for the period ended Dec 31, 2014

Filed with the SEC on Feb 10, 2015 and accepted by EDGAR at Feb 10, 2015, 16:48 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-10-01 to 2014-12-31$37.05bnus-gaap:Revenues
Revenue12 months2014-01-01 to 2014-12-31$139.37bnus-gaap:Revenues
Cost of revenue12 months2014-01-01 to 2014-12-31$114.00bnus-gaap:CostOfRevenue
Gross profit3 months2014-10-01 to 2014-12-31$6.63bnus-gaap:GrossProfit
Gross profit12 months2014-01-01 to 2014-12-31$25.37bnus-gaap:GrossProfit
Operating income3 months2014-10-01 to 2014-12-31$2.32bnus-gaap:OperatingIncomeLoss
Operating income12 months2014-01-01 to 2014-12-31$8.80bnus-gaap:OperatingIncomeLoss
Interest expense12 months2014-01-01 to 2014-12-31$615.0mus-gaap:InterestExpense
Income tax12 months2014-01-01 to 2014-12-31$3.03bnus-gaap:IncomeTaxExpenseBenefit
Net income3 months2014-10-01 to 2014-12-31$1.32bnus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Diluted EPS3 months2014-10-01 to 2014-12-31$1.14us-gaap:EarningsPerShareDiluted
Diluted EPS12 months2014-01-01 to 2014-12-31$3.96us-gaap:EarningsPerShareDiluted
Basic EPS3 months2014-10-01 to 2014-12-31$1.15us-gaap:EarningsPerShareBasic
Basic EPS12 months2014-01-01 to 2014-12-31$3.98us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2014-01-01 to 2014-12-311,169,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2014-01-01 to 2014-12-31$8.14bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2014-01-01 to 2014-12-31$2.14bnus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid12 months2014-01-01 to 2014-12-31$1.29bnus-gaap:PaymentsOfDividends
Share repurchases12 months2014-01-01 to 2014-12-31$4.00bnus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2014-12-31$2.48bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-12-31$25.98bnus-gaap:AssetsCurrent
Total assetsAt period end2014-12-31$74.25bnus-gaap:Assets
Current liabilitiesAt period end2014-12-31$19.03bnus-gaap:LiabilitiesCurrent
Long-term debtAt period end2014-12-31$11.70bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2014-12-31$575.0mus-gaap:LongTermDebtCurrent
Short-term borrowingsAt period end2014-12-31$685.0mus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2014-12-31$37.96bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000064803-15-000008. Last ingested by Listed: Nov 6, 2026, 17:47 ET. Listed shows no prices and gives no investment advice.